Invention Grant
- Patent Title: Composition for treating cancer stem cells
-
Application No.: US15522558Application Date: 2015-10-28
-
Publication No.: US10420814B2Publication Date: 2019-09-24
- Inventor: Jae Ho Cheong , Eun Sung Park , Ki Cheong Park
- Applicant: Bio Synosia Co., Ltd.
- Applicant Address: KR Seoul
- Assignee: Haimbio Co., Ltd.
- Current Assignee: Haimbio Co., Ltd.
- Current Assignee Address: KR Seoul
- Agency: McDonnell Boehnen Hulbert & Berghoff LLP
- Priority: KR10-2014-0147972 20141029
- International Application: PCT/KR2015/011436 WO 20151028
- International Announcement: WO2016/068600 WO 20160506
- Main IPC: A61K31/351
- IPC: A61K31/351 ; A61P35/00 ; A61K38/10 ; A61K31/70 ; A61K31/455 ; A61K31/155 ; A61K31/7004

Abstract:
The present invention relates to a composition for effectively treating cancer stem cells, and more specifically to a composition for treating cancer stem cells, which contains a glucose uptake inhibitor, a biguanide-based compound, and a calcium pump inhibitor. The composition of the present invention can be used as an agent of treating cancer stem cells by effectively inducing apoptosis of the cancer stem cells. Accordingly, the composition of the present invention can be used as a pharmaceutical composition capable of effectively treating various cancer stem cells to effectively inhibiting cancer recurrence and/or metastasis.
Public/Granted literature
- US20170312333A1 Composition for Treating Cancer Stem Cells Public/Granted day:2017-11-02
Information query